BIOFIRE MOLECULAR ANALYZER AT NHCP

SOL #: HT941026PE064Award Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)
DEFENSE HEALTH AGENCY HCD WEST
CAMP PENDLETON, CA, 92055, United States

Place of Performance

Camp Pendleton, CA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 8, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency (DHA) has awarded a Firm Fixed Price contract for Molecular Assay Analyzer Cost Per Test (CPT) services at the Naval Hospital Camp Pendleton (NHCP) Laboratory Department in Camp Pendleton, CA. This Unrestricted award, with a total potential value of $4,651,935.82, was effective on April 8, 2026.

Scope of Work

The contract covers the provision of Molecular Assay Analyzer Cost Per Test (CPT) services, which includes the supply of analyzers, necessary reagents, ongoing maintenance, and consumables. These services are specifically for the NHCP Laboratory Department. The scope references Attachment 01 - Statement of Work (SOW) and Attachment 03 - Vendor Quotes for detailed requirements.

Contract Details

  • Contract Number: HT941026PE064
  • Award/Effective Date: April 8, 2026
  • Pricing Arrangement: Firm Fixed Price
  • Total Potential Value: $4,651,935.82 (Base: $425,647.66; Options: $4,226,288.16)
  • Base Period: April 15, 2026 to September 30, 2026
  • Option Periods: Five option years, extending from October 1, 2026 to April 14, 2031
  • Set-Aside: Unrestricted
  • NAICS Code: 334516 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
  • Size Standard: 1000 employees

Additional Notes

FAR clauses 52.212-1, 52.212-3, and 52.212-4 are incorporated by reference. Payment will be handled by DFAS-INDY VP GFEBS, utilizing Wide Area WorkFlow (WAWF) for electronic invoicing and payment requests. Key points of contact for pre-award, post-award, MTF, and delivery are available.

People

Points of Contact

Files

Files

Download

Versions

Version 1Viewing
Award Notice
Posted: Apr 8, 2026
BIOFIRE MOLECULAR ANALYZER AT NHCP | GovScope